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ABSTRACT
Background: Asthma is difficult to diagnose in children and at times misdiagnosis of an infection can occur.
However, little is known about the magnitude and patterns of antibiotic consumption in children with asthma
relative to those without asthma.
Methods: Using population-based data, 128,872 children were identified with at least 6 years of follow-up. The
adjusted rate-ratio (RR) of antibiotics dispensed to asthmatic as compared to non-asthmatic children was
determined.
Results: At age six, the RR of antibiotic consumption for asthmatics compared to non-asthmatics varied between,
1.66 to 2.32, depending on the year of asthma diagnosis. Of the 18,864 children with asthma at ages 2-8, 52% (n =
9,841) had antibiotics dispensed in the 6 months prior to their index date of asthma diagnosis. The RR of antibiotic
consumption in the 1 month prior to asthma diagnosis compared to 5 months prior was 1.66 (95% CI 1.60-1.71).
The RR was lower in males compared to females (1.58 vs 1.77), and lower in those who received antibiotics in the
first year of life relative to those that did not (1.60 vs. 1.76).
Conclusions: There is higher antibiotic consumption in children with asthma compared to those without asthma.
The pattern of antibiotic use suggests that diagnosis guidelines are difficult to follow in young children leading to
misdiagnosis and over treatment with antibiotics.
Background
Studies performed in varying populations over the last
30 years have indicated that the prevalence of asthma
has significantly increased [1,2]. Asthma rates are parti-
cularly high in children with one in eight school chil-
dren being affected [3]. Asthma is difficult to diagnose -
particularly in children as frequently their only symptom
is coughing which may be mistaken for an upper
respiratory tract infection in addition to the fact that
they cannot participate in many of the standard diagnos-
tic tests. The North American guidelines [4,5] for pedia-
tric asthma management outline a stepwise approach to
asthma management with the aim being to initiate con-
trol of asthma with regular anti-inflammatory therapy
and monitor the level of control by use of rescue medi-
cation as well as symptoms, and in older children with
assessment of airflow obstruction [6,7]. As such, patients
should start treatment that is consistent with the initial
severity of their asthma and then step down when con-
trol has been achieved. The availability of guidelines
does not necessarily mean a high uptake by clinicians.
Several studies have evaluated the use of asthma medi-
cations in adults and children and have shown that 40
to 60% of prescribing does not reflect the recommenda-
tions in guidelines [8-10].
In contrast to the use of asthma medications, antibio-
tics are over utilized in children and often prescribed
for viral infections [11-15]. Our recent studies have eval-
uated the use of antibiotics in Canadian children and we
showed that although overall antibiotic use had declined
over a decade, their use in a Canadian population
exceeds that of European children [11]. In addition, the
use of antibiotics in children under 4 years of age, was
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any medium, provided the original work is properly cited.double that of children between 10-14 years of age - and
was primarily associated with upper respiratory tract
infections, acute otitis media and bronchitis [12].
We know that antibiotics are not routinely used in the
treatment of asthma - the asthma treatment guidelines
clearly state that although symptoms associated with
poor asthma control often overlap with symptoms asso-
ciated with respiratory tract infections, clinicians should
take care in differentiating between the two conditions.
We conducted this study to determine the patterns of
antibiotic consumption in children with asthma. Specifi-
cally, we wanted to determine if antibiotic consumption
was greater in children who developed asthma com-
p a r e dt ot h o s ew h od i dn o ta n dt oe x a m i n et h er a t eo f
antibiotic consumption prior to the diagnosis of asthma.
Methods
Study Population
The longitudinal study cohort consisted of all live births
in British Columbia (BC), Canada, from January 1997
through December 2003. Follow-up information was
available from all data files up to December 2005.
Data Sources
We used population-based, linked administrative health
data that contained information on all physician services
(known as MSP), hospital admissions, vital status infor-
mation, socioeconomic status (SES) (determined
through postal code and census classifications such as
median neighbourhood income and split by quintiles
therefore those in neighborhoods reporting the greatest
20% of incomes in the population will be in the 5th
quintile) and outpatient dispensing episodes of prescrip-
tion drugs (PharmaNet) to assess potential antibiotic
exposures, potential confounders, and outcomes. Lin-
kages among the various data files were achieved
through the use of a personal health number unique to
every BC resident; all traceable personal identifiers were
removed to protect patient confidentiality. Ethics
approval was obtained from the University of British
Columbia Behavioral Research Ethics Board.
Information on dispensed asthma drugs and antibiotics
between 1997 and 2005 was extracted based on the 2009
Anatomical Therapeutic Chemical Classification System
(ATC) codes [16]. Asthma medications (ATC codes
R03A-D) consisted of short-acting b-agonists, inhaled
corticosteroids, ipratropium, or leukotriene receptor
antagonists and ketotifen (ATC code R06AX17). Antibio-
tics (ATC code J01) were classified as penicillins, cepha-
losporins, macrolides, sulfonamide, or other classes.
Physician visits in the database were classified accord-
ing to the 3-digit diagnostic code (International Classifi-
cation of Diseases, Ninth Revision (ICD-9)) associated
with that visit and the type of physician (e.g. general
practitioner versus specialist). These visits were also
extracted in the year prior to asthma diagnosis. In addi-
tion, any visits to an allergist, respirologist, or immunol-
ogist visit were obtained. Similar codes were used to
classify hospitalizations.
Asthma Definition and Index Date
The definition of asthma employed in our study was
either: (1) a hospital discharge for asthma (ICD9 493);
or (2) two medical fee-for-service claims coded ICD9
493 within a moving 12-month period; or (3) two pre-
scriptions for a known asthma medication within a mov-
ing 12-month period. The index date was defined as the
d a t eo ft h ef i r s te p i s o d eb yw h i c ht h ed i a g n o s i so f
asthma was established. Previous research comparing
various database asthma definitions to a gold standard
of an allergist’s diagnosis of childhood asthma found
that this definition of asthma had a positive predictive
value of 92%, which was higher than other definitions
requiring fewer visits and prescriptions [17,18].
Statistical Analysis
Antibiotic rates in asthmatics versus controls
Rates of antibiotic dispensing in asthmatics and non-
asthmatics by age 6 were examined in those with at
least 6 years of follow-up from birth (n = 128,872). We
defined five groups according to their asthma diagnosis
in this period: ‘no asthma by age 6’ or asthma definition
reached at age 2, 3, 4, and 5 years. Asthmatics reaching
the index date within their first two years of life (n =
22,736) were excluded since the diagnosis of asthma is
difficult and confounded by other illnesses and the rate
of antibiotic dispensing was high and variable in this age
range. Annual antibiotic dispensing rates until age 6
years were calculated in these five cohorts. As previous
work has shown changes in antibiotic prescribing rates
in this population over time [12], we adjusted for calen-
dar year in all analyses. Rate ratios for antibiotic dispen-
sing in the four asthma groups compared to the ‘no
asthma by age 6’ reference group were also plotted.
Antibiotic rates near the asthma index date
We examined incident asthma cases identified prospec-
tively from age two years until the earliest of: 31st
December 2005, death, or departure from BC (n =
18,864). For children not registered in the MSP on 31st
December 2005, the date of departure from BC was
defined as the latest occurrence of: MSP coverage, MSP
visits, hospital separations, or PharmaNet records. This
allowed follow-up up to capture asthma diagnosed to a
maximum age of 8 years. The monthly rates of antibio-
tic and asthma medication dispensing were plotted by
age at asthma index date in those followed for 6 months
prior to and also for 6 months post the asthma index
date (n = 17,297).
Marra et al. BMC Pulmonary Medicine 2011, 11:32
http://www.biomedcentral.com/1471-2466/11/32
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ratios (RR) and their 95% confidence intervals (CI) for
the rate of antibiotic dispensing in the six months prior
to the index date adjusting for the various potential con-
founders. As the number of antibiotics dispensed per
child was overdispersed, the deviance chi-square was
used to adjust the standard errors. Potential confoun-
ders adjusted for included gender, birth weight, and
congenital anomalies. Time varying covariates included
calendar year, seasonality, child age, and in the preced-
ing year: quintiles of socioeconomic status (SES), fre-
quency of physician visits, and allergist/respirologist/
immunologist visit.
To calculate the RR and 95% CI for the antibiotic pre-
scribing rate in the month before the index date compared
to the 5 months before that, Poisson models were used
with general estimating equations to obtain robust stan-
dard errors accounting for the correlation between the
two rates being estimated for each child [19]. Interactions
between the RR and all of the confounders were tested in
a Poisson model and results were presented for confoun-
ders that independently significantly altered this RR.
To examine indications for antibiotics prescribing in
the six months prior to the index date, the infectious
diagnosis (according to ICD9 codes) were reported for
the most temporal MSP billing code within 5 days pre-
ceding the dispensing episode. Proportions of the indica-
tions for antibiotic prescribing in the month prior to the
index date and the 5 months prior to that were com-
pared via chi-square tests.
Results
Antibiotic rates in asthmatics versus controls
For those 106,136 children with at least 6 years of fol-
low-up (excluding asthmatics reaching their index date
in the first 2 years of life), 96,496 (91%) did not meet
the definition of asthma by age 6 years and the remain-
ing met the definition at age 2 (2.6%), 3 (2.4%), 4 (2.1%)
and 5 (1.9%). The asthmatics first met the criteria for
diagnosis in 57% of cases via a medical claim, 53% by
prescription, and 5% by hospital discharge. 12% met the
criteria for asthma diagnosis by medical claim and pre-
scription simultaneously. The rates of antibiotic pre-
scribing by year of age and by age at the asthma index
date (adjusted for calendar year - presented for year
2000) were characterized for these children (Table 1).
The rate was elevated in the asthmatics compared to
the non-asthmatics and this ratio peaked during the
year of asthma diagnosis with a RR of around 2.30-2.36
(Table 1).
Antibiotic rates near the asthma index date
A total of 18,864 children first met our definition of
asthma between their 2nd birthday and 31 December
2005. Antibiotics were dispensed to 9,841 (52%) of these
children in the 6 months leading up to their asthma
index date. They were dispensed 17,245 courses of anti-
biotics during this period and 4,293 (25%) of these anti-
biotics were dispensed in the month before the index
date. The three most frequently antibiotics/type of anti-
biotics dispensed were amoxicillin (45%), macrolides
(29%) and cephalosporins (14%). Antibiotic dispensing
increased prior to the asthma index date and rapidly
decreased in the 6 months afterwards (Figure 1). Very
few asthma medications were dispensed prior to the
asthma index date, a large rate dispensed on the asthma
index date (61% of asthmatics dispensed asthma medica-
tions on the index date), and then a level similar to that
of antibiotic dispensing afterwards (around 200 per 100
PY) (Figure 2).
Exposure to antibiotics in the first year of life was
associated with increased antibiotic dispensing in the 6
months prior to the index date (RR 1.26, 95% CI 1.22-
1.30) in the multivariable model (Table 2). In addition,
visiting a specialist in the previous year (RR 0.85, 95%
CI 0.75-0.96) and congenital anomalies (RR 0.93, 95%
CI 0.88-0.98) were associated with lower antibiotic dis-
pensing. Asthma diagnosed in spring and summer was
associated with a greater rate of antibiotics being dis-
pensed in the previous 6 months than asthma diagnosed
in the winter or fall. A decreasing rate of antibiotics dis-
pensing was observed across increasing SES quintiles
with the highest SES quintile being associated with 0.91
(95% CI, 0.86-0.96) fold fewer antibiotics being dis-
pensed. Also an increasing rate of dispensing was
observed across increasing frequencies of physician visits
in the last year, so those visiting a physician ≥ 12 times
in the previous year were dispensed antibiotics 7.79
(95% CI, 7.13-8.51) times more frequently relative to
those visiting a physician <12 times.
The rate of antibiotic dispensing one month prior to
the index date was elevated (RR 1.66, 95% CI 1.60-1.71)
compared to the immediate 5 months before this (Table
3). Gender, season, SES, visit to a specialist, and fre-
quency of physician visits in the year prior to diagnosis
all independently modified this RR. Specifically, in the
subgroup analysis, the rate of antibiotic dispensing in
girls and boys was significantly higher in the one month
prior to the index date as compared to the 5 months
prior (RR 1.77, 95% 1.68-1.87 and 1.58; 95% CI 1.51 -
1.65, respectively). Similarly, those who had not visited a
specialist in the year prior had a higher ratio (RR 1.67,
95% 1.61-1.73) relative to those that had. The RR was
g r e a t e ri nt h ef a l la n dw i n t e rt h a ns p r i n ga n ds u m m e r ,
although all seasons were associated with a significantly
greater rate of antibiotic dispensing one month prior to
the index rate than in the previous 5 months. The ratios
were also higher for those with fewer physician visits in
Marra et al. BMC Pulmonary Medicine 2011, 11:32
http://www.biomedcentral.com/1471-2466/11/32
Page 3 of 10the prior year and those with a lower SES. For example,
those with ≤2 physician visits (RR 2.22, 95% CI 1.86-
2.64) and those in the lowest SES quintile (RR 1.70, 95%
CI 1.59-1.82) had a higher rate of antibiotic dispensing
in the one month prior to the index date compared to
the 5 months prior.
Upper and lower respiratory tract infections (RTIs),
otitis media and bronchitis were the most frequent diag-
noses preceding the antibiotic dispensations in the 6
months prior to the index date (Table 4). Lower RTI
and bronchitis were more frequently associated with
antibiotic dispensing in the one month before the index
date compared to the 5 months before. Upper RTI,
acute otitis media, lower urinary tract infection, and
skin/soft tissue infection were less frequently associated
with antibiotic dispensing in the one month before the
index date compared to the 5 months before that.
Discussion
This is the first study to clearly show a pattern of
increased consumption of antibiotics in children in the
period immediately before the diagnosis of asthma.
Those children who were eventually diagnosed with
asthma had a higher rate of antibiotic use than those
who were never diagnosed with asthma during the
follow up period of the study. However, the rate of anti-
biotic use was at the highest in the year that asthma
was diagnosed. Specifically, in the one month period
leading up to their first asthma-related episode, children
with asthma were almost 1.7 times more likely to
r e c e i v ea na n t i b i o t i cp r e s c r i p t i o nt h a ni nt h ef i v e
months prior. In addition, these children were more
likely to receive a diagnosis of a lower respiratory tract
infection or bronchitis rather than asthma in this time
p e r i o d .T h i sf i n d i n g ,c o u p l e dw i t ht h ef a c tt h a tt h o s e
children that were ultimately diagnosed with asthma
h a dah i g h e rb a s e l i n er a t eo fa n t i b i o t i cc o n s u m p t i o n ,
highlights the need for clinicians to diagnosis asthma in
children promptly and not to inappropriately prescribe
antibiotics, especially in those with respiratory
symptoms.
Antibiotics are an important component of treating
bacterial infections in both adults and children. But
their overuse has important public health consequences
as it leads to drug resistance [20-24]. Several studies
have showed that antibiotic use in Canadian children is
not only higher than their European counterparts but
that penicillins are more likely to be prescribed in Eur-
ope compared to macrolides in Canadian children
[11,12]. Furthermore, clinicians should also keep in
Table 1 Rates of antibiotics dispensed per year of age, by age of asthma diagnosis and rate ratios compared to non-
asthmatics by age 6 (rates standardized for year 2000)
No asthma by age 6
(n = 96,496)
Age at asthma index date
Age 2 (n = 2,791) Age 3 (n = 2,572) Age 4 (n = 2,238) Age 5 (n = 2,039)
Age,
years
Rate of ABX per 100
PY
Rate of ABX
per 100 PY
RR (95%
CI)*
Rate of ABX
per 100 PY
RR (95%
CI)*
Rate of ABX
per 100 PY
RR (95%
CI)*
Rate of ABX
per 100 PY
RR (95%
CI)*
0 84.6 123.9 1.47
(1.40-
1.53)
118.5 1.40
(1.34-
1.47)
110.8 1.31
(1.25-
1.38)
108.3 1.28
(1.22-
1.35)
1 118.8 190.1 1.60
(1.54-
1.66)
173.4 1.46
(1.40-
1.52)
165.0 1.39
(1.33-
1.45)
156.4 1.32
(1.26-
1.46)
2 90.1 213.0 2.36
(2.28-
2.45)
149.0 1.65
(1.58-
1.73)
140.2 1.56
(1.48-
1.63)
124.9 1.39
(1.32-
1.46)
3 89.0 170.0 1.91
(1.84-
1.99)
207.5 2.33
(2.24-
2.42)
156.8 1.76
(1.68-
1.84)
136.9 1.54
(1.46-
1.62)
4 85.7 148.1 1.73
(1.65-
1.80)
162.1 1.89
(1.81-
1.97)
197.0 2.30
(2.20-
2.40)
141.9 1.66
(1.57-
1.74)
5 85.8 143.3 1.67
(1.60-
1.75)
147.2 1.72
(1.64-
1.79)
164.0 1.91
(1.83-
2.00)
198.1 2.31
(2.21-
2.41)
Before
age 6
91.5 162.5 1.77
(1.75-
1.80)
156.7 1.72
(1.69-
1.74)
152.2 1.66
(1.63-
1.69)
141.0 1.55
(1.51-
1.58)
* compared to rate of ABX in those without asthma by age 6 and adjusted for calendar year
Abbreviations: ABX - antibiotics; PY - person years; RR - rate ratio
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of shortness of breath and wheezing may have an infec-
tion but for the most part it is viral rather than bacter-
ial, negating the need for antibiotics [25]. As such,
much of the antibiotic use documented in this study
may have been avoidable. Given the high probability of
cough and shortness of breath in young children being
due to a viral infection or possibly non-infectious cause
(e.g., asthma), a “watch and wait” approach [26-28] is
advocated for upper respiratory tract infections and fre-
quently for otitis media. Asthma guidelines have been
shown to be effective in controlling antibiotic prescrib-
ing in this regard but are often challenging to imple-
ment [29].
It is well known that the diagnosis of asthma in chil-
dren less than 5 years of age is difficult and related to
the fact that episodic wheezing and shortness of breath
are also present in children who do not have asthma
[30]. In addition, there is a challenge to objectively mea-
suring airflow obstruction in this age group especially in
primary care where access to spirometry in all age
groups is not readily available. Thus, guidelines suggest
the following as having a high positive predictive value
of asthma in children - frequent (more then once a
month) episodes of wheeze, activity induced cough or
wheeze, nocturnal cough when the child does not have
a viral infection, absence of seasonal variation in wheeze
and persistence of respiratory symptoms after the age of
3 years. In young children, the diagnosis of asthma is
based on a clinician’s judgment, symptomatic improve-
ment after a trial of therapy with inhaled corticosteroids
and use of a short acting beta-agonist for symptom
relief. In our study, we partially circumvented the pro-
blem by excluding all asthma diagnoses in the first two
years of life. In addition, the patterns of antibiotic use
were the same for older children (5 years old and
greater) as younger children (< 5 yrs) increasing the
confidence of our results in younger children.
Several of our observations require further thought.
The strongest associations occurred in children from
lower socioeconomic status. Our data do not allow for a
definitive statement regarding this phenomenon. How-
ever, since higher socioeconomic status is associated
with higher education, it is possible that parents of
h i g h e rs o c i o e c o n o m i cs t a t u sw e r em o r ei n q u i s i t i v eo f
the child’s care leading to the consideration of alternate
diagnoses other than infection. Also, we found that
f e m a l e sw e r em o r el i k e l yt oh a v eah i g h e rn u m b e ro f
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Figure 1 Monthly rate of antibiotic medication dispensing per 100 person-years by months before and months after asthma index
date and by age at asthma index date* (Age (years) at asthma index date: blue diamonds = 3, pink squares = 4, yellow triangles = 5,
turquoise crosses = 6, purple stars = 7, brown circles = 8-9). * N = 17,297 with 6 months follow-up before and 6-months follow-up post
asthma index date
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Page 5 of 10prescriptions for antibiotics prior to the diagnosis of
asthma. Given that asthma is more common in prepu-
bescent boys than in girls, this result seems counterin-
tuitive. However, given this difference in incidence
physicians may be even more reluctant to consider
asthma as a diagnosis for girls in this age group and
therefore are more likely to prescribe more antibiotics.
Another finding of note included that exposure to anti-
biotics in the first year of life was associated with
increased antibiotic dispensing in the 6 months prior to
the index date. Despite the fact that the frequency of
physician visits were adjusted for in the analysis, it is
possible that this finding might be due to residual con-
founding due to treatment seeking behavior. Finally, we
found that asthma diagnosed in spring and summer was
associated with a greater rate of antibiotics being dis-
pensed in the previous 6 months than asthma diagnosed
in the winter or fall. A possible explanation for this find-
ing is that, due to the presence of allergens in the spring
and summer, clinicians might experience patients with
more severe respiratory infections and can easily rule
out seasonal influenza as the cause. As such, more anti-
biotics are prescribed during these seasons. All of these
findings merit further examination in well-conducted
prospective studies.
Our study is not without limitations. Due to the nat-
ure of the data, many important potential confounders
(such as birth order, family history of allergic disease,
maternal smoking) could not be adjusted for in the mul-
tivariable models. However, these variables are unlikely
to impact the main analysis which showed an increased
rate of antibiotic prescription just before the diagnosis
of asthma.
There are many ways to define asthma diagnosis in
administrative data [31-33]. We employed a method
that was developed and validated by researchers in
Canada although on a slightly older group of asthmatics
[18]. However, it is possible that, by using this method,
we have misclassified some children as asthmatics
whose symptoms subsequently resolve. In addition, the
converse is also possible with some asthmatic children
being classified as non-asthmatic. It’s likely there is phy-
sician and possibly parental reluctance, to consider
asthma as a diagnosis given the potential implications
such a label brings. For example, Their et al showed
that physicians were very likely to prescribe inhaled cor-
ticosteroids for children with asthma but only a small
minority of patients had their prescription filled [34]. As
such, these patients might be misclassified in an admin-
istrative database study.
0
200
400
600
800
1000
1200
1400
-6 -5 -4 -3 -2 -1 0 1 2 3 4 5 6
Time since index date (months)
I
n
c
i
d
e
n
c
e
 
o
f
 
a
s
t
h
m
a
 
m
e
d
i
c
a
t
i
o
n
s
 
 
 
(
p
e
r
 
1
0
0
P
Y
)
Figure 2 Monthly rate of asthma medication dispensing per 100 person-years by months before and months after asthma index date
and by age at asthma index date* (Age (years) at asthma index date: blue diamonds = 3, pink squares = 4, yellow triangles = 5,
turquoise crosses = 6, purple stars = 7, brown circles = 8-9). * N = 17,297 with 6 months follow-up before and 6-months follow-up post
asthma index date
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Page 6 of 10Table 2 Multivariable rate ratios of antibiotic dispensing in six months prior to the index date
Confounder n % Rate of ABX per 100 PY (6 months prior to diagnosis) RR 95% CI p
Age at asthma diagnosis
2 6,254 33.2 209.9 1.00 <.0001
3 4,810 25.5 185.5 1.03 0.98 - 1.07
4 3,316 17.6 164.4 1.00 0.95 - 1.05
5 2,338 12.4 171.9 1.10 1.04 - 1.17
6 1,272 6.7 153.9 1.03 0.96 - 1.12
7-8 874 4.6 117.4 0.89 0.81 - 0.99
Year of asthma diagnosis
1999 475 2.5 226.9 1.00 <.0001
2000 1,484 7.9 207.8 0.98 0.88 - 1.09
2001 2,165 11.5 206.0 1.03 0.93 - 1.14
2002 2,924 15.5 178.0 0.95 0.86 - 1.06
2003 3,494 18.5 180.4 0.97 0.88 - 1.07
2004 4,351 23.1 174.2 0.98 0.89 - 1.08
2005 3,971 21.1 171.3 1.05 0.95 - 1.16
Season of asthma diagnosis
Winter 5,085 27.0 179.9 1.00 <.0001
Spring 5,140 27.2 217.8 1.24 1.19 - 1.30
Summer 3,142 16.7 194.9 1.13 1.07 - 1.18
Fall 5,156 27.3 150.6 0.85 0.81 - 0.89
Antibiotic exposure in first year
No 8,542 45.3 145.6 1.00 <.0001
Yes 10,322 54.7 213.8 1.26 1.22 - 1.30
Gender
Female 7,762 41.2 181.0 1.00 0.38
Male 11,102 58.9 184.3 0.99 0.95 - 1.02
Allergist/respirologist/immunologist visit (in last year)
No 18,487 98.0 182.7 1.00 0.008
Yes 377 2.0 196.7 0.85 0.75 - 0.96
Congenital anomalies (in first year)
No 16,943 89.8 182.0 1.00 0.006
Yes 1,921 10.2 190.9 0.93 0.88 - 0.98
SES in the year before diagnosis (quintiles of whole population)*
First quintile 4,357 23.1 201.6 1.00 0.004
Second quintile 4,074 21.6 189.8 0.98 0.94 - 1.03
Third quintile 3,744 19.9 185.4 0.98 0.93 - 1.03
Fourth quintile 3,290 17.4 170.0 0.95 0.90 - 1.00
Fifth quintile 2,744 14.6 157.9 0.91 0.86 - 0.96
Unknown 655 3.5 171.3 1.05 0.96 - 1.15
Physician visits in last year
0-2 2,838 15.0 44.3 1.00 <.0001
3-4 3,147 16.7 92.5 2.07 1.87 - 2.29
5-9 4,626 24.5 147.3 3.31 3.02 - 3.62
10-12 4,308 22.8 220.7 4.91 4.49 - 5.37
>12 3,945 20.9 355.3 7.79 7.13 - 8.51
Birth weight (kg) 0.92
< 1.5 177 0.9 185.3 1.00
1.5 - 2.5 923 4.9 195.2 1.01 0.85 - 1.21
2.5 - 3.5 9,593 50.9 185.6 1.01 0.86 - 1.19
3.5 - 4.5 7,748 41.1 179.0 1.03 0.87 - 1.22
> 4.5 401 2.1 169.6 1.01 0.83 - 1.23
Unknown 22 0.1 127.3 0.93 0.52 - 1.66
Abbreviations: ABX - antibiotics; PY - person years; RR - rate ratio
* Socioeconomic status by neighbourhood income quintiles - the fifth is the highest income quintile and the first is the lowest income quintile.
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cult in those less than 5 years of age but believe that the
consistency of our results between the younger (<
5years) and older (> or = to 5 years) is a validation of
our definition. Although we document an association
between antibiotic use and the diagnosis of asthma, our
study does not address the issue of whether asthma is
caused by antibiotics or is an associated finding.
Table 3 Rate ratios of the frequency of antibiotic dispensing in month before the index date compared to 5 months
before in significant subgroups
Rate of ABX per Rate of ABX per Rate of ABX in month before diagnosis vs 5 months before
100 PY (month 100 PY (1-6 months
Subgroup n % before diagnosis) before diagnosis) RR 95% CI p
Overall 18,864 100.0 273.1 164.9 1.66 1.60 - 1.71 <.0001
Gender
Female 7,762 41.2 284.5 160.4 1.77 1.68 - 1.87 <.0001
Male 11,102 58.9 265.1 168.1 1.58 1.51 - 1.65 <.0001
Season of asthma diagnosis
Winter 5,085 27.0 336.3 155.1 2.17 2.04 - 2.30 <.0001
Spring 5,140 27.2 290.9 202.9 1.43 1.35 - 1.53 <.0001
Summer 3,142 16.7 210.8 191.7 1.10 1.00 - 1.21 0.04
Fall 5,156 27.3 249.0 131.2 1.90 1.77 - 2.04 <.0001
Allergist/respirologist/immunologist visit (in last year)
No 18,487 98.0 274.1 164.4 1.67 1.61 - 1.73 <.0001
Yes 377 2.0 213.2 193.4 1.10 0.80 - 1.51 0.54
Physician visits in last year (quintiles)
0-2 2,838 15.0 81.6 36.8 2.22 1.86 - 2.64 <.0001
3-4 3,147 16.7 155.2 80.0 1.94 1.73 - 2.18 <.0001
5-9 4,626 24.5 228.3 131.2 1.74 1.61 - 1.88 <.0001
10-12 4,308 22.8 336.2 197.6 1.70 1.59 - 1.82 <.0001
>12 3,945 20.9 488.5 328.6 1.49 1.41 - 1.57 <.0001
SES in the year before diagnosis (quintiles of whole population)
First quintile 4,357 23.1 204.5 120.4 1.70 1.59 - 1.70 <.0001
Second quintile 4,074 21.6 185.6 114.8 1.62 1.51 - 1.62 <.0001
Third quintile 3,744 19.9 195.9 109.1 1.80 1.66 - 1.80 <.0001
Fourth quintile 3,290 17.4 165.1 103.0 1.60 1.47 - 1.60 <.0001
Fifth quintile 2,744 14.6 146.4 97.1 1.51 1.36 - 1.51 <.0001
Abbreviations: ABX - antibiotics; PY - person years; RR - rate ratio
* Socioeconomic status by neighborhood income quintiles - the fifth is the highest income quintile and the first is the lowest income quintile.
Table 4 Most common diagnoses related to antibiotics dispensed in the 6 months prior to the index date (N = 17,245
antibiotic prescriptions)
One month before 1-6 months before Six months before
Diagnosis (ICD9 code) Number of antibiotic
prescriptions
% Number of antibiotic
prescriptions
% Number of antibiotic
prescriptions
%
Upper respiratory tract infection
(034, 461-465)
993 23.1 3062 23.6 4055 23.1
Bronchitis (466, 490-491)* 785 18.3 1658 12.8 2443 13.9
Acute otitis media (381-382)* 544 12.7 2140 16.5 2684 15.3
Lower respiratory tract infection
(481-486)*
211 4.9 386 3.0 597 3.4
Skin/soft tissue infection (035, 680-
686)*
39 0.9 205 1.6 244 1.4
Lower urinary tract infection (595,
597, 599)*
25 0.6 206 1.6 231 1.3
Asthma (493) 9 0.2 20 0.2 29 0.2
* p < 0.01 for chi-square test for difference in proportion of antibiotics dispensed due to that diagnosis in the previous month compared to 5 months before
that.
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to prove conclusively without a clinical trial which
would obviously be prohibited by ethical issues. How-
ever, the pattern of use of antibiotics and the immediate
reduction in their use post-asthma diagnosis suggests
that antibiotics were being used for asthmatic wheeze.
This assumption is strengthened by considered the rea-
sons for antibiotic prescription leading up to the asthma
diagnosis (bronchitis and upper respiratory infections).
Conclusions
Our study shows an increased use of antibiotics in chil-
dren ultimately diagnosed with asthma compared to
children without this diagnosis and use of antibiotics is
highest just before the diagnosis of asthma. This sug-
gests that clinicians are initially slow to respond to a
pattern of cough as being due to asthma but rather label
it as an acute infection. In the setting where antibiotics
are often prescribed, a wait and see approach and earlier
consideration of the possibility of asthma would lead to
a faster resolution of symptoms and the establishment
of a correct diagnosis. Less use of antibiotics would also
facilitate a lower risk for the development of bacterial
resistance as well as the avoidance of antibiotic related
morbidity linked to adverse events. We therefore pro-
pose that the prescription of more than two courses of
antibiotics for respiratory symptoms in a child over a six
month period should be sufficient to warrant considera-
tion of an asthma diagnosis.
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